| Net Cash Provided by (Used in) Operating Activities |
$117,635 |
USD |
2.9% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$630,000 |
USD |
|
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$37,600 |
USD |
|
Q4 2024 |
Q1 2026 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
81,335,812 |
shares |
9% |
Q4 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$512,365 |
USD |
|
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,102,715 |
USD |
309% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$6,118,577 |
USD |
5.7% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$5,070,788 |
USD |
5.4% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q4 2025 |
Q1 2026 |
| Additional Paid in Capital |
$46,049,708 |
USD |
6.2% |
Q4 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q1 2026 |